Boston Scientific’s spinal cord stimulators approved for non-surgical back pain
February 7, 2024
FDA backing for the Wavewriter SCS systems allows the company to challenge Abbott and Nevro.
FDA backing for the Wavewriter SCS systems allows the company to challenge Abbott and Nevro.
BETHLEHEM, Pa., Feb. 6, 2024 /PRNewswire/ — Tyber Medical LLC, a leading orthopedic device manufacturer providing private label orthopedic implants for the trauma, extremity, and spine markets, received clearance for the anatomical plating system in Canada. The comprehensive portfolio previously received FDA 510(k) in the US and has now been cleared through Health Canada.
A Prospective, Randomized, Multicenter Study Assessing the Safety and Efficacy of the ReCET™ System in Adult Patients with Type 2 Diabetes
Element Science announced that it received CE mark approval for its novel patch-wearable cardioverter defibrillator (P-WCD).
The single-use, PEEK-based RIB System utilizes the platform technology of Able’s Valkyrie® Thoracic Fixation System, further strengthening Able Medical’s portfolio.
Intuitive Surgical (Nasdaq: ISRG)+
announced today that it received CE mark approval for its da Vinci SP surgical robot platform.
Zoll this week announced it received FDA clearance and CE mark approval for upgrades to its Thermogard temperature management system
Pulse Biosciences (Nasdaq:PLSE) today announced the
The clearance positions BD and partner Babson Diagnostics to support blood collection from community sites such as pharmacies.
LivaNova (NASDAQ: LIVN)+
says it’s the latest victim of a cybersecurity incident.